User profiles for MR Turner

Martin R. Turner

Nuffield Department of Clinical Neurosciences, Oxford University
Verified email at ndcn.ox.ac.uk
Cited by 26942

[HTML][HTML] Amyotrophic lateral sclerosis

MC Kiernan, S Vucic, BC Cheah, MR Turner, A Eisen… - The lancet, 2011 - thelancet.com
Amyotrophic lateral sclerosis (ALS) is an idiopathic, fatal neurodegenerative disease of the
human motor system. In this Seminar, we summarise current concepts about the origin of the …

Amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria

…, J Rosenfeld, V Silani, PG Ince, MR Turner - … lateral sclerosis and …, 2017 - Taylor & Francis
This article presents the revised consensus criteria for the diagnosis of frontotemporal
dysfunction in amyotrophic lateral sclerosis (ALS) based on an international research workshop …

Controversies and priorities in amyotrophic lateral sclerosis

MR Turner, O Hardiman, M Benatar, BR Brooks… - The Lancet …, 2013 - thelancet.com
Two decades after the discovery that 20% of familial amyotrophic lateral sclerosis (ALS)
cases were linked to mutations in the superoxide dismutase-1 (SOD1) gene, a substantial …

Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study

…, LA Benjamin, A Carson, C Smith, MR Turner… - The Lancet …, 2020 - thelancet.com
Background Concerns regarding potential neurological complications of COVID-19 are being
increasingly reported, primarily in small series. Larger studies have been limited by both …

Texture discrimination by Gabor functions

MR Turner - Biological cybernetics, 1986 - Springer
A 2D Gabor filter can be realized as a sinusoidal plane wave of some frequency and
orientation within a two dimensional Gaussian envelope. Its spatial extent, frequency and …

Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study

MR Turner, A Cagnin, FE Turkheimer, CCJ Miller… - Neurobiology of …, 2004 - Elsevier
Microglial activation is implicated in the pathogenesis of ALS and can be detected in animal
models of the disease that demonstrate increased survival when treated with anti-…

[PDF][PDF] A proposal for new diagnostic criteria for ALS

…, N Simon, M Swash, K Talbot, MR Turner… - Clinical …, 2020 - ora.ox.ac.uk
Turner o, Yoshikazu Ugawa p, Leonard H. van den Berg q, Renato Verdugo r, Steven Vucic
… signs for at least 4 years after disease onset (Turner et al., 2020). These patients have a …

Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis

…, C Tortorella, A Trentini, M Troiano, MR Turner… - JAMA …, 2019 - jamanetwork.com
Importance Neurofilament light protein (NfL) is elevated in cerebrospinal fluid (CSF) of a
number of neurological conditions compared with healthy controls (HC) and is a candidate …

Biomarkers in amyotrophic lateral sclerosis

MR Turner, MC Kiernan, PN Leigh, K Talbot - The Lancet Neurology, 2009 - thelancet.com
Amyotrophic lateral sclerosis (ALS; motor neuron disease) is a relentlessly progressive
disorder. After half a century of trials, only one drug with modest disease-modifying potency—…

Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis

…, K Talbot, L Greensmith, J Kuhle, MR Turner… - Neurology, 2015 - AAN Enterprises
Objective: To test blood and CSF neurofilament light chain (NfL) levels in relation to disease
progression and survival in amyotrophic lateral sclerosis (ALS). Methods: Using an …